Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

60 health systems sign Epic’s letter against interoperability rule

An HHS rule that would enable patients to have free access to their medical records through third-party digital apps is facing a tough battle, with one of the biggest EMR vendor companies, Epic Systems, leading the opposition.

Thumbnail

E-cigarette rules go into effect

New rules about e-cigarettes went into effect Feb. 6, with a partial ban on some flavored products in the U.S. market.

Thumbnail

CMS wants patients to know the cost of Part D drugs in real time in proposed rule

CMS has issued a proposed rule and Advance Notice affecting Medicare Advantages and Medicare Part D prescription drug plans.

Thumbnail

Top 10 biggest health insurance companies

The top 10 largest insurers collectively wrote 51.8% of all healthcare premiums in the U.S. market in 2018.

Thumbnail

Trump asks for bill to lower drug prices in State of the Union address

President Donald Trump gave his annual State of the Union address on Feb. 4, calling on Congress to take on sky-high prescription drug prices.

In Iowa caucuses, healthcare issue takes center stage

Healthcare was top of mind among Iowa caucus-goers as the start of the 2020 election kicked off in the state on Feb. 3. About 60% of Democrats at the Iowa caucuses said they support eliminating private health insurance and moving to a single-payer healthcare system.

Thumbnail

Coronavirus is deadly and expensive

The novel coronavirus, which originated in Wuhan, China, has become the world’s most expensive epidemic, according to data from Learnbonds.com. In fact, the virus, which has been compared to SARS and MERS, is expected to cost China about 2% of its GDP during the first quarter of 2020, or $62 billion.

 

Thumbnail

Former Aetna CEO cites ‘tension’ in CVS board changes

The former CEO of health insurer Aetna, which was acquired by CVS Health for $69 billion at the end of 2018, says he is being pushed off the board of the combined company.

 

Displaying 825 - 832 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup